Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Danaher Corporation
  6. Summary
    DHR   US2358511028

DANAHER CORPORATION

(DHR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
321.45(c) 324.09(c) 325.26(c) 324(c) 324.53(c) Last
2 032 358 1 888 372 2 353 290 1 794 074 3 362 373 Volume
-2.59% +0.82% +0.36% -0.39% +0.16% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 28 687 M - -
Net income 2021 6 144 M - -
Net Debt 2021 14 651 M - -
P/E ratio 2021 39,1x
Yield 2021 0,27%
Sales 2022 30 362 M - -
Net income 2022 6 100 M - -
Net Debt 2022 10 731 M - -
P/E ratio 2022 39,6x
Yield 2022 0,29%
Capitalization 232 B 232 B -
EV / Sales 2021 8,59x
EV / Sales 2022 7,98x
Nbr of Employees 68 000
Free-Float 74,2%
More Financials
Company
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies... 
Read more
More about the company
Ratings of Danaher Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about DANAHER CORPORATION
09/15DANAHER CORP /DE/ : Change in Directors or Principal Officers, Financial Stateme..
AQ
09/14DANAHER : Keeps Quarterly Cash Dividend Unchanged at $0.21 a Share, Payable Oct...
MT
09/14DANAHER : Announces Quarterly Dividends
PR
09/14Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on Octo..
CI
09/10DANAHER : Credit Suisse Raises Danaher's PT to $370 from $306, Notes Heightened ..
MT
09/08DANAHER : RBC Raises Price Target on Danaher to $332 From $304 Ahead of Analyst ..
MT
09/03DANAHER : Helping Customers Make Better Beer -- and Improve Sustainability
PU
09/01SCIEX : Presents Industry First Multi-Capillary System for CE-SDS, the BioPhase ..
BU
09/01SCIEX : Builds on Cadence of Innovation in Biopharma With Biologics Explorer
BU
08/30DANAHER : Closes $9.6 Billion Acquisition Deal for Aldevron
MT
08/30DANAHER : Completes Acquisition of Aldevron
PR
08/30Danaher Corporation completed the acquisition of Aldevron, LLC from EQT VIII ..
CI
08/25DANAHER : To Webcast Investor And Analyst Meeting
PR
08/24DANAHER CORP /DE/ : Change in Directors or Principal Officers, Financial Stateme..
AQ
08/24Danaher Names New Human-Resources, Accounting Chiefs
DJ
More news
News in other languages on DANAHER CORPORATION
09/14Danaher Corporation approuve un dividende trimestriel régulier en espèces, pa..
09/13Deux valeurs dans la santé qui mériteraient d'être plus connues
08/11LE TOUR D’HORIZON DES ETF : Quatre produits à objectifs vertueux
04/22STOCK MARKET PARIS : Biden, Lagarde et un déluge de publications
04/22EN DIRECT DES MARCHES  : Renault, Hermès, Orange, Pernod Ricard, Ipsen, Nestlé, ..
More news
Analyst Recommendations on DANAHER CORPORATION
More recommendations
Stock Trading Strategies
DANAHER CORPORATION - 06/22
The beginning of the move
BUY
More Stock Trading Analysis
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | MarketScreener
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 324,53 $
Average target price 327,00 $
Spread / Average Target 0,76%
EPS Revisions
Managers and Directors
Rainer M. Blair President, Chief Executive Officer & Director
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Steven M. Rales Chairman
Jose Carlos Gutiérrez Ramos Chief Science Officer & Senior Vice President
Brian W. Ellis Senior Vice President & General Counsel
Sector and Competitors
1st jan.Capi. (M$)
DANAHER CORPORATION45.85%231 682
THERMO FISHER SCIENTIFIC20.32%234 792
INTUITIVE SURGICAL, INC.26.79%123 426
SIEMENS HEALTHINEERS AG39.64%77 234
EDWARDS LIFESCIENCES CORPORATION32.29%74 438
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-14.79%68 250